Supernus Pharmaceuticals, Inc. (SUPN)
54.73
-1.02
(-1.83%)
USD |
NASDAQ |
Feb 27, 16:00
54.78
+0.05
(+0.09%)
After-Hours: 20:00
Supernus Pharmaceuticals Research and Development Expense (TTM) : 104.64M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.498B |
| BridgeBio Pharma, Inc. | 451.95M |
| Corcept Therapeutics, Inc. | 254.91M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Cytokinetics, Inc. | 405.90M |